首页> 外文会议>European Congress of Immunology >Role of chemokine signaling in the pathogenesis of Good's syndrome - a preliminary study.
【24h】

Role of chemokine signaling in the pathogenesis of Good's syndrome - a preliminary study.

机译:趋化因子信号在良好综合征发病机制中的作用 - 初步研究。

获取原文

摘要

Good's syndrome (GS), is a rare coincidence of thymoma and hypogammaglo-bulinemia. It is also marked by a reduction in number (or absence) of B cells. B and T cell deficiency in thymoma patients is sometimes referred to as GS, but it represents rather a different disease with distinct etiology and pathogenesis.The coincidence of involvement of two central immune organs (bone marrow and thymus) may indicate that lymphocyte circulation in GS is defective. In GS the enlargement of thymus and simultaneous atrophy of B-cell compartment in bone marrow direct to the hypothesis that GS may arise due to defective mobilization of common lymphocyte precursors (CLP) to thymus and insufficient homing of cells to bone marrow (BM). Cell migration occurs in response to the relative levels of chemokines, i.e. homing to marrow compartment depends on the increased level of CXCL12 (SDF-1) in the BM. Previous study indicated that low CXCR4 membrane expression on CD34(+) cells characterizes cells with potential to be mobilized to peripheral blood. The same phenomenon may underlay the pathogenesis of GS. In this paper we describe two patients with Good syndrome of mild and high grade, who were tested for expression of CXCR4 (a SDF-1 receptor) on cells in blood and bone marrow. Patient (E.W.) presented with : (i) mild hypogammaglobulinemia, sporadically demanding intravenous immunoglobulin substitution , (ii) low percentage of CD20+ cells in peripheral blood ( 1,4% in lymphocytes population ), and (iii) a thymic enlargement of moderate degree. Patient (E.P.) suffered from: (i) severe hypogammaglobulinemia (IgG approx=60mg/dl), (ii) absence of CD20+ cells in peripheral blood (0.04% lymphocytes), and (iii) severe thymic enlargement. The first patient (E.W.) presented with CXCR4 expression on 82.6% of lymphocytes in BM, the other patient (E.P.) on 46.3%. Interestingly, the bone marrow of patient with severe form of GS (thymic enlargement, E.P.) contained more CD10-positive than BM of the E.W. (11,38% vs. 0.1% cells). CD10 (endopeptidase, enkephalinase), which is capable of cleaving many small molecular weight peptides, may limit activity of chemokines, for example SDF-1. This data indicate that SDF-1 may promote homing of lymphoid precursors to BM, and inhibit migration to the vascular niche as well as migration of CLPs to the thymus. In contrast weak expression of CXCR4 and SDF-1 signal favors vigorous CLP migration to the thymus, and thymoma development (especially predominantly lymphocytic) in Good's syndrome.
机译:良好的综合症(GS),是胸腺瘤和低血清葡萄糖血症的罕见巧合。它也标志着B细胞的数量(或不存在)。 B和T细胞缺乏胸腺瘤患者有时被称为GS,但它代表着具有不同病因和发病机制的不同疾病。两个中枢免疫器官(骨髓和胸腺)的致命的巧合可能表明GS中的淋巴细胞循环有缺陷。在GS中,由于常见的淋巴细胞前体(CLP)与胸腺缺乏和细胞归巢给胸骨骨髓(BM)的术语,骨髓中B细胞室的B细胞室中B细胞室的同时萎缩的扩大和同时萎缩。响应于趋化因子的相对水平而发生细胞迁移,即与骨髓隔室归巢取决于BM中的CXCL12(SDF-1)的增加。先前的研究表明,CD34(+)细胞上的低CXCR4膜表达表征具有动力调动到外周血的细胞。同样的现象可以介绍GS的发病机制。在本文中,我们描述了两种良好的温和和高品位综合症的患者,用于表达CXCR4(SDF-1受体)对血液和骨髓细胞的表达。患者(ew)呈现:(i)温和的低血管胰腺炎血症,偶尔静脉内免疫球蛋白替代,(ii)外周血(淋巴细胞群中1,4%)的CD20 +细胞百分比低(III)的静脉扩大。患者(E.P.)患有:(i)严重的低氧胺(IgG约= 60mg / dl),(ii)在外周血(0.04%淋巴细胞)中没有CD20 +细胞,和(iii)严重的胸腺增大。第一个患者(例如)在BM的BM中的82.6%的淋巴细胞上呈现CXCR4表达,其他患者(例如)含有46.3%。有趣的是,具有严重GS的患者的骨髓(胸腺增大,例如,E.P.)含有比E.W的BM更多CD10阳性。(11,38%对0.1%细胞)。能够切割许多小分子量肽的CD10(内肽酶,苯胺酶)可以限制趋化因子的活性,例如SDF-1。该数据表明SDF-1可以促进淋巴前体的归巢至BM,并抑制对血管利基的迁移以及CLPS对胸腺的迁移。相比之下,CXCR4和SDF-1信号的弱表达有利于剧烈的CLP迁移到胸腺和胸腺瘤发育(特别是主要淋巴细胞),良好的综合症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号